FDA Approves a New PARP Inhibitor for BRCA-mutant Breast Cancer
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
In the midst of Breast Cancer Awareness Month, the US. Food and Drug Administration (FDA) provided good news for...
Breast cancer is the most commonly diagnosed cancer in the United States. In 2018, 266,120 women and 2,550 men...
In my first post in this series highlighting some of the studies presented at the AACR Annual Meeting 2015...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...